Anupam Rasayan buys Jayhawk for $150m in 2026

Deal announcement in brief

Anupam Rasayan has announced a $150 million acquisition of US-based Jayhawk Fine Chemicals, a move that gives the Indian specialty chemicals maker its first onshore manufacturing base in the United States. The company also described the transaction as its largest global deal to date. Jayhawk is positioned as a manufacturer with capabilities in high value chemistries used across semiconductors, aviation and advanced materials. For Anupam Rasayan, the acquisition adds a physical manufacturing footprint in a key end-market geography at a time when customers in electronics and advanced materials continue to focus on supply assurance and qualification. The announcement comes alongside multiple customer engagements and letters of intent (LOIs) referenced by the company, spanning battery chemicals and niche fluorination-led products.

What Anupam Rasayan is buying

Jayhawk Fine Chemicals is described as a US-based manufacturer with strong capabilities in high value chemistries. The company’s stated exposure includes applications across semiconductors, aviation and advanced materials. Anupam Rasayan has not, in the provided text, disclosed additional operating metrics for Jayhawk, such as capacity, profitability or customer concentration. What is clear is the strategic value highlighted by Anupam Rasayan: this is its first onshore US manufacturing base. The company has framed this as a step change in its global footprint, and the largest transaction it has done internationally.

Why an onshore US base matters for customers

The stated end-markets for Jayhawk overlap with segments where qualification cycles are long and supply continuity matters. Semiconductor-related chemistries often require consistent quality, robust compliance systems, and repeatable process performance. Aviation and advanced materials customers can also place high emphasis on traceability and dependable delivery, particularly for mission-critical applications. By acquiring an onshore US manufacturer, Anupam Rasayan is adding a domestic production option for American customers, rather than serving them only through cross-border shipments. The company’s commentary also places the acquisition within a broader push into niche, high value molecules.

Japan partnership: master purchase agreement for niche molecules

During the quarter, Anupam Rasayan said it signed a long-term master purchase agreement with a Japan-based multinational conglomerate described as a global leader in fluorochemicals and advanced technology solutions. The company indicated the arrangement has immediate as well as long-term commercial value. It also said it is collaborating with this Japanese conglomerate to supply multiple niche molecules used across diverse applications, including semiconductors, data centers and electronics. According to the commentary, several of these molecules are slated for commercialization this year, with production ramping up from next year onwards. The company linked this engagement to its strengths in fluorination and custom synthesis.

Battery ecosystem push: LOI with E-Lyte and FUCHS

Anupam Rasayan has also signed an LOI with E-Lyte Innovations GmbH and FUCHS LUBRICANTS GERMANY GmbH for long-term supply of lithium hexafluorophosphate (LiPF6), a lithium-ion battery component. The LOI envisions a supply volume of up to 1,500 tonnes per annum (TPA) of LiPF6, based on market conditions. Commercial deliveries are indicated as potentially starting in FY 2026-2027. The text also notes that FUCHS LUBRICANTS GERMANY GmbH has been a strategic partner and minority shareholder in E-Lyte since 2022. Anupam Rasayan linked its position in fluorine chemistry to this opportunity, including backward integration through Tanfac Industries Ltd.

Elementium Materials: advanced electrolyte chemical development and supply

Separately, the company has signed a contract and LOI with US-based Elementium Materials for development and supply of chemicals in an advanced electrolyte critical for EV batteries. Supply is expected to commence from the end of FY26, as per the regulatory filing referenced in the text. Upon successful product development, the companies plan to negotiate a five-year supply agreement. The company indicated cumulative sales in the range of $150 million to $150 million for that potential five-year arrangement. Management commentary in the provided text also suggests initial quantities can be supplied through existing facilities, while a full ramp-up post FY26 may require a new plant, with plant sizing and CapEx details to be shared once finalized.

Other disclosed customer wins: Korean LOI and German contract renewal

The text also references a 10-year LOI with a leading Korean multinational company. That deal is valued at $106 million, described as approximately ₹922 crore, and involves supplying a high-performance specialty chemical from FY26. The Korean firm is described as a leader in specialty chemicals for aviation and electronics applications. In addition, Anupam Rasayan has renewed a long-term contract with a leading German multinational for supply of a patented life science specialty chemical. While product-level details and volumes for that renewal are not specified in the provided text, it adds to the broader theme of repeat business and multi-year engagements.

Order book and India manufacturing base

Anupam Rasayan stated that its order book stands at ₹14,646 crore after the new agreements. The company also operates six manufacturing facilities in Gujarat with aggregate installed capacity of about 30,000 metric tonnes (MT) as of March 31, 2025. In management commentary included in the text, the company indicated it is making efforts to optimise its balance sheet and working capital. The same commentary also flagged expectations of strong revenue growth across four segments: agro, pharma, polymer and personal care, with personal care described as steadier due to lower volatility.

Key numbers at a glance

What the combined announcements signal

Taken together, the Jayhawk acquisition and the string of LOIs underline a focus on niche chemistries tied to electronics, aviation, advanced materials and battery supply chains. The acquisition adds an onshore US base, while the customer engagements span Japan, the US, Germany and South Korea. The disclosed volumes and timelines show that some opportunities are nearer term, while others depend on development milestones and ramp-ups into FY26 and beyond. The company has also indicated that several niche molecules under the Japanese agreement are slated for commercialization this year, with production ramping up next year. For investors, the key monitorables implied in the text are execution on timelines, scaling from existing facilities versus new capacity requirements, and conversion of LOIs into contracted revenues.

Conclusion

Anupam Rasayan’s $150 million Jayhawk Fine Chemicals acquisition marks a significant step in building an onshore US manufacturing presence, while the company continues to add multi-year engagements in battery and advanced materials-linked chemistries. The next set of concrete milestones flagged in the text include commercialization of select niche molecules this year, production ramp-up from next year, and supply commencement from end-FY26 for the Elementium-linked electrolyte opportunity.